US EditionStudy raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic
About 80,000 people in the Netherlands are prescribed GLP-1 drugs, but weight is typically regained within two years after stopping treatment, researchers say.
5 Articles
5 Articles
Study raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic
Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these drugs than after diet and exercise alone. Improvements in heart health and diabetes risk also tend to reverse within a few years. The results suggest long-term success may require more than medication alone.
General practitioners are increasingly prescribing weight-loss medication. This is almost double the number from 2024, according to figures from the Dutch Pharmaceutical Key Figures Foundation. An estimated 80,000 people currently use medications like Ozempic and Wegovy to lose weight. Until now, these medications were only prescribed to people with diabetes. The increase is mainly due to the updated general practitioner guidelines for obesity, …
The success of Ozempic, an antidiabetic, puts the health care budget under pressure. In order for the patient to still be eligible for a refund, he will have to have a prior agreement of his mutual as of 1 February. ...
A simple injection has gone on to occupy headlines all over the world. GLP-1-based treatments, born to control type 2 diabetes, have become the great medical sensation because of their effect on appetite and weight loss, to the point of opening a new therapeutic field that already explore very different specialties. In Spain, Ozempic already has competence in pharmacies with names like Mounjaro and Wegovy. Well. In full expansion of these drugs,…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
